Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
Serretta V, Morgia G, Altieri V, Di Lallo A, Ruggiero G, Salzano L, Battaglia M, Falsaperla M, Zito A, Sblendorio D, Melloni D, Allegro R; members of Gruppo Studi Tumori Urologici (GSTU) Foundation. Serretta V, et al. Among authors: morgia g. BJU Int. 2010 Jul;106(2):212-7. doi: 10.1111/j.1464-410X.2009.09153.x. Epub 2010 Jan 11. BJU Int. 2010. PMID: 20070299 Clinical Trial.
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study.
Gontero P, Oderda M, Altieri V, Bartoletti R, Cai T, Colombo R, Curotto A, Di Stasi S, Maffezzini M, Tamagno S, Serretta V, Sogni F, Terrone C, Tizzani A, Morgia G, Mirone V, Carmignani G. Gontero P, et al. Among authors: morgia g. Urol Int. 2011;86(1):19-24. doi: 10.1159/000321926. Epub 2010 Dec 30. Urol Int. 2011. PMID: 21196690 Free article.
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Verze P, Battaglia M, Serretta V, Russo GI, Morgia G, Musi G, de Cobelli O, Mirone V, Shariat SF. Ferro M, et al. Among authors: morgia g. Urol Int. 2018;101(1):7-15. doi: 10.1159/000490765. Epub 2018 Jul 4. Urol Int. 2018. PMID: 29975950
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.
Racioppi M, Salmaso L, Brombin C, Arboretti R, D'Agostino D, Colombo R, Serretta V, Brausi M, Casetta G, Gontero P, Hurle R, Tenaglia R, Altieri V, Bartoletti R, Maffezzini M, Siracusano S, Morgia G, Bassi PF. Racioppi M, et al. Among authors: morgia g. Urol Int. 2015;94(3):262-9. doi: 10.1159/000365292. Epub 2014 Aug 27. Urol Int. 2015. PMID: 25171377
Management of symptomatic benign prostatic hyperplasia in southern Italy: a retrospective analysis of the Sicilian-Calabrian Society of Urology (SSCU) of 32,000 patients.
Serretta V, Morgia G, Fondacaro L, Curto G, Pirritano D, Lo Bianco A, Melloni D, Orestano F, Motta M, Pavone-Macaluso M; Members of the Sicilian-Calabrian Society of Urology. Serretta V, et al. Among authors: morgia g. Urol Int. 2003;71(1):16-21. doi: 10.1159/000071087. Urol Int. 2003. PMID: 12845254
232 results